Preclinical CRO Market Research Report - Forecast till 2032^®

Precision Medicine Market is predictable to reach a valuation of USD 5,234.7 million by 2024 growing at a 8.14% CAGR from 2019 to 2024, market has been largely benefited by the growth in outsourcing of non-core functions, enhanced abilities of preclinical CROs to offer additional value-added services, surging number of drugs in the preclinical phase, economies of production & scale, mutual benefit to the contractor as well as the client and high R&D expenditure